Simplifying Global Compliance
FDAnews Drug Daily Bulletin
QRxPharma, FDA Establish Path Forward for Resubmission of Moxduo NDA
Jan. 17, 2013
QRxPharma Limited announced the steps necessary for approval of immediate release Moxduo (morphine and oxycodone) have been clarified with the FDA.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing